Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer 10/10/2023 INTERVENTIONAL not-comparable 1,096.75 0 Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium 10/10/2023 INTERVENTIONAL not-comparable 1,096.75 0 Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients 10/10/2023 OBSERVATIONAL not-comparable 1,096.75 0 Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT). 10/10/2023 INTERVENTIONAL not-comparable 1,096.75 0 Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome 10/10/2023 INTERVENTIONAL not-comparable 1,096.75 0 MIRACLE of LIFE Study 10/10/2023 OBSERVATIONAL not-comparable 1,096.75 0 Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) 10/10/2023 INTERVENTIONAL not-comparable 1,096.75 0 DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment 10/10/2023 INTERVENTIONAL not-comparable 1,096.75 0 Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations 10/10/2023 OBSERVATIONAL not-comparable 1,096.75 0 Sexual Function and Quality of Life After LEEP: a Prospective Multi-Center Study 10/12/2023 OBSERVATIONAL not-comparable 1,094.75 0 Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) 10/12/2023 INTERVENTIONAL not-comparable 1,094.75 0 Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania 10/12/2023 INTERVENTIONAL not-comparable 1,094.75 0 Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction 10/12/2023 INTERVENTIONAL not-comparable 1,094.75 0 Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali 10/12/2023 INTERVENTIONAL not-comparable 1,094.75 0 Curcumin Supplementation in Cervical Cancer 10/12/2023 INTERVENTIONAL not-comparable 1,094.75 0 Micronutrient Dose Response Study in Bangladesh 10/13/2023 INTERVENTIONAL not-comparable 1,093.75 0 NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III) 10/13/2023 INTERVENTIONAL not-comparable 1,093.75 0 Pectoral Nerve Block Versus Paravertebral Block In The Incidence of Chronic Pain After Breast Cancer Surgery 10/13/2023 INTERVENTIONAL not-comparable 1,093.75 0 Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood 10/13/2023 OBSERVATIONAL not-comparable 1,093.75 0 Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2 10/13/2023 INTERVENTIONAL not-comparable 1,093.75 0 Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) 10/13/2023 OBSERVATIONAL not-comparable 1,093.75 0 Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context 10/16/2023 INTERVENTIONAL not-comparable 1,090.75 0 Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy 10/16/2023 INTERVENTIONAL not-comparable 1,090.75 0 Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging 10/16/2023 INTERVENTIONAL not-comparable 1,090.75 0 A Study of Sovilnesib in Subjects With Ovarian Cancer 10/16/2023 INTERVENTIONAL not-comparable 1,090.75 0 Emgality for Migraine in Breastmilk 10/16/2023 OBSERVATIONAL not-comparable 1,090.75 0 Cancer Pain Management Using a Web-based Intervention 10/16/2023 INTERVENTIONAL not-comparable 1,090.75 0 Patients Derived Organoids in Ovarian Cancer 10/17/2023 INTERVENTIONAL not-comparable 1,089.75 0 Study of 18F-FFNP Breast PET/MRI 10/17/2023 INTERVENTIONAL not-comparable 1,089.75 0 Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment 10/17/2023 OBSERVATIONAL not-comparable 1,089.75 0 Prenatal Starting Early Program mHealth 10/17/2023 INTERVENTIONAL not-comparable 1,089.75 0 PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy 10/18/2023 INTERVENTIONAL not-comparable 1,088.75 0 Analgesic Efficacy of Different Nerve Blocks in Postoperative Cesarean Section 10/18/2023 INTERVENTIONAL not-comparable 1,088.75 0 PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery 10/18/2023 OBSERVATIONAL not-comparable 1,088.75 0 Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. 10/19/2023 INTERVENTIONAL not-comparable 1,087.75 0 ESPBs vs TAPs for Satisfactory Analgesia Following DIEP Surgery 10/19/2023 INTERVENTIONAL not-comparable 1,087.75 0 Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) 10/19/2023 INTERVENTIONAL not-comparable 1,087.75 0 IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases 10/23/2023 INTERVENTIONAL not-comparable 1,083.75 0 Improving Overactive Bladder Treatment Access and Adherence 10/23/2023 INTERVENTIONAL not-comparable 1,083.75 0 Telehealth Multi-Component Optional Model (MOM) Study 10/23/2023 INTERVENTIONAL not-comparable 1,083.75 0 Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome 10/24/2023 INTERVENTIONAL not-comparable 1,082.75 0 Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women 10/24/2023 OBSERVATIONAL not-comparable 1,082.75 0 The Correlation Between Ovarian Function and Serum Biomarkers 10/24/2023 OBSERVATIONAL not-comparable 1,082.75 0 International Non-selection Study for ERA® Test in Patients With Previous Implantation Failures 10/24/2023 OBSERVATIONAL not-comparable 1,082.75 0 Looking for a Blood Epigenetic Signature to Predict Female Infertility 10/24/2023 OBSERVATIONAL not-comparable 1,082.75 0 Breast Cancer Resiliency Through Exercise Program (B-REP) 10/25/2023 INTERVENTIONAL not-comparable 1,081.75 0 Endometriosis Pain 10/26/2023 OBSERVATIONAL not-comparable 1,080.75 0 Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) 10/26/2023 INTERVENTIONAL not-comparable 1,080.75 0 The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section 10/26/2023 INTERVENTIONAL not-comparable 1,080.75 0 Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia 10/26/2023 INTERVENTIONAL not-comparable 1,080.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology